HSY
32
3
IRM
33
5
CME
59
3
ADP
57
2
CAG
34
3
D
32
10
DVA
62
5
CVS
27
2
PYPL
49
4
NWSA
69
4
FITB
36
3
DUK
49
4
TXT
46
4
GOOG
77
14
STX
34
2
VMC
41
2
NTRS
35
10
ADI
54
4
TXN
29
4
EW
55
5
HSY
32
3
IRM
33
5
CME
59
3
ADP
57
2
CAG
34
3
D
32
10
DVA
62
5
CVS
27
2
PYPL
49
4
NWSA
69
4
FITB
36
3
DUK
49
4
TXT
46
4
GOOG
77
14
STX
34
2
VMC
41
2
NTRS
35
10
ADI
54
4
TXN
29
4
EW
55
5
Financhill
Back

Assembly Biosciences 10K Form

Sell
26

ASMB
Assembly Biosciences

Last Price:
$15.17
Seasonality Move:
15.3%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ASMB News And Ratings

See the #1 stock for the next 7 days that we like better than ASMB

ASMB Financial Statistics

Sales & Book Value

Annual Sales: $7.2M
Cash Flow: $-15.2M
Price / Cash Flow: 3.78
Annual Sales: $4.09
Price / Book: 3.7

Profitability

EPS (TTM): -6.92000
Net Income (TTM): $-40.8M
Gross Margin: $0
Return on Equity: -115.86%
Return on Assets: -38.94%

Assembly Biosciences Earnings Forecast

Key Assembly Biosciences Financial Ratios

  • The Selling, General & Administrative Expenses for ASMB have been equal to 319.82% of Gross Profit Margin.
  • The Research & Development expenses have been 682.67% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 16 years have been positive in 11 years.

Assembly Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ASMB
CUSIP: 045396
Website: assemblybio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.36
Quick Ratio: 2.28

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ASMB Technical Analysis vs Fundamental Analysis

Sell
26
Assembly Biosciences (ASMB) is a Sell

Is Assembly Biosciences a Buy or a Sell?